Xcout IntelSign inSubscribe

Akorn

PharmaceuticalsUnited States

Akorn, Inc. is a pharmaceutical company with its main headquarters located in Lake Forest, Illinois, alongside various manufacturing and operational facilities.

Subscribe to see Akorn’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Akorn at a glance

Akorn is a pharmaceuticals company headquartered in United States. Its most recent funding round, Grant, closed in September 2025.

Industry
Pharmaceuticals
Headquarters
United States

Akorn funding rounds

Every round on record:

DateRoundAmountInvestors
GrantUndisclosed—
GrantUndisclosed1 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

Akorn competitors

A few of Akorn's closest competitors — see the full list of competitors and alternatives →

Bausch Health Companies Inc.BHC · PharmaceuticalsLaval, Canada
63% matchPublic

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Market cap$1.8B
Employees20,300
Bausch Health Companies Inc. competitors & alternatives →

Get Akorn's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Akorn — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Akorn in Xcout Intel

  • 2 funding rounds with the investors in each, and who they co-invest with
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →